Metoprolol succinate contraindications
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Succinate Contraindications
Introduction to Metoprolol Succinate
Metoprolol succinate is a long-acting beta-blocker commonly used to manage various cardiovascular conditions, including hypertension, angina, and heart failure. Despite its widespread use, certain contraindications must be considered to ensure patient safety.
Heart Failure and Left Ventricular Dysfunction
Metoprolol succinate has been shown to be beneficial in patients with heart failure. A study investigating its effects on left ventricular ejection fraction (LVEF) found that it significantly improved LVEF and reduced ventricular ectopic beats over a six-month period . This indicates that metoprolol succinate is generally safe and well-tolerated in heart failure patients, provided it is administered under careful medical supervision.
Perioperative Use in Non-Cardiac Surgery
The POISE trial examined the effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery. While the trial found that metoprolol succinate reduced the incidence of myocardial infarction, it also highlighted significant risks. Specifically, there was an increased incidence of stroke and overall mortality in the metoprolol group compared to the placebo group . These findings suggest that the use of metoprolol succinate in the perioperative setting should be approached with caution, particularly in patients at risk of stroke or other complications.
Contraindications and Cautions
Absolute Contraindications
- Severe Bradycardia: Metoprolol succinate should not be used in patients with severe bradycardia, as it can further reduce heart rate and lead to adverse outcomes.
- Second or Third-Degree Heart Block: Patients with these conditions should avoid metoprolol succinate unless they have a functioning pacemaker.
- Cardiogenic Shock: The use of metoprolol succinate is contraindicated in patients experiencing cardiogenic shock due to its negative inotropic effects.
Relative Contraindications
- Asthma and Chronic Obstructive Pulmonary Disease (COPD): Beta-blockers can exacerbate bronchospasm in patients with reactive airway diseases.
- Diabetes Mellitus: Metoprolol succinate can mask hypoglycemic symptoms, necessitating careful monitoring of blood glucose levels.
- Peripheral Vascular Disease: Caution is advised as beta-blockers can potentially worsen symptoms of peripheral vascular disease.
Conclusion
While metoprolol succinate is effective in managing certain cardiovascular conditions, its use must be carefully considered in specific patient populations. Contraindications such as severe bradycardia, heart block, and cardiogenic shock must be strictly observed. Additionally, caution is warranted in patients with asthma, diabetes, and peripheral vascular disease. The increased risks identified in the perioperative setting further underscore the need for careful patient selection and monitoring when prescribing metoprolol succinate.
Sources and full results
Most relevant research papers on this topic